RecruitingPhase 3NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Anaheim, CA · Fresno, CA · Long Beach, CA · +29 more sites
5 recruiting migraine studies with a site in Anaheim, CA.
Sponsor: AbbVie
Anaheim, CA · Fresno, CA · Long Beach, CA · +29 more sites
Sponsor: AbbVie
Anaheim, CA · Long Beach, CA · Oceanside, CA · +39 more sites
Sponsor: Pfizer
Anaheim, CA · Costa Mesa, CA · Culver City, CA · +166 more sites
Sponsor: Pfizer
Anaheim, CA · Culver City, CA · Fresno, CA · +112 more sites
Sponsor: AbbVie
Anaheim, CA · Fresno, CA · La Palma, CA · +122 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.